Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marina S. Boukhvalova, Emma Mortensen, Aissatou Mbaye, Jamall McKay & Jorge C.G. Blanco. (2021) Effect of aging on immunogenicity and efficacy of inactivated influenza vaccines in cotton rats Sigmodon hispidus. Human Vaccines & Immunotherapeutics 17:1, pages 133-145.
Read now
Read now
Steven G Reed. (2013) Vaccine adjuvants. Expert Review of Vaccines 12:7, pages 705-706.
Read now
Read now
Articles from other publishers (32)
Luciane Almeida Amado, Wagner Luis da Costa Nunes Pimentel Coelho, Arthur Daniel Rocha Alves, Vanessa Cristine de Souza Carneiro, Otacilio da Cruz Moreira, Vanessa Salete de Paula, Andreza Salvio Lemos, Larissa Araujo Duarte, Elisa Gouvea Gutman, Fabricia Lima Fontes-Dantas, João Paulo da Costa Gonçalves, Carlos Henrique Ferreira Ramos, Carlos Henrique Ferreira Ramos Filho, Marta Guimarães Cavalcanti, Marisa Pimentel Amaro, Rafael Lopes Kader, Roberto de Andrade Medronho, Dmitry José de Santana Sarmento & Soniza Vieira Alves-Leon. (2023) Clinical Profile and Risk Factors for Severe COVID-19 in Hospitalized Patients from Rio de Janeiro, Brazil: Comparison between the First and Second Pandemic Waves. Journal of Clinical Medicine 12:7, pages 2568.
Crossref
Crossref
Brenda Rodrigues Silva, Fernanda Rodrigues Monteiro, Kizzy Cezário, Jônatas Bussador do Amaral, Vitória Paixão, Ewin Barbosa Almeida, Carlos André Freitas dos Santos, Gislene Rocha Amirato, Danielle Bruna Leal Oliveira, Edison Luiz Durigon, Andressa Simões Aguiar, Rodolfo P. Vieira, Juliana de Melo Batista dos Santos, Guilherme Eustáquio Furtado, Carolina Nunes França, Marina Tiemi Shio & André Luis Lacerda Bachi. (2023) Older Adults Who Maintained a Regular Physical Exercise Routine before the Pandemic Show Better Immune Response to Vaccination for COVID-19. International Journal of Environmental Research and Public Health 20:3, pages 1939.
Crossref
Crossref
Robert C. Mettelman & Paul G. Thomas. (2021) Human Susceptibility to Influenza Infection and Severe Disease. Cold Spring Harbor Perspectives in Medicine 11:5, pages a038711.
Crossref
Crossref
Shyh Poh Teo. (2021) Review of COVID-19 Vaccines and Their Evidence in Older Adults. Annals of Geriatric Medicine and Research 25:1, pages 4-9.
Crossref
Crossref
Boris G Andryukov & Natalya N Besednova. (2021) Older adults: panoramic view on the COVID-19 vaccination. AIMS Public Health 8:3, pages 388-415.
Crossref
Crossref
Peter B Gilbert, Youyi Fong, Michal Juraska, Lindsay N Carpp, Arnold S Monto, Emily T Martin & Joshua G Petrie. (2019) HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy. BMC Infectious Diseases 19:1.
Crossref
Crossref
Ajitanuj Rattan, Katherine A. Richards, Zackery A. G. Knowlden & Andrea J. Sant. (2019)
Protein Vaccination Directs the CD4
+
T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection
. Journal of Virology 93:20.
Crossref
Crossref
Sophia Ng, Raffael Nachbagauer, Angel Balmaseda, Daniel Stadlbauer, Sergio Ojeda, Mayuri Patel, Arvind Rajabhathor, Roger Lopez, Andrea F. Guglia, Nery Sanchez, Fatima Amanat, Lionel Gresh, Guillermina Kuan, Florian Krammer & Aubree Gordon. (2019) Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nature Medicine 25:6, pages 962-967.
Crossref
Crossref
Kathleen Ross, Sujata Senapati, Jessica Alley, Ross Darling, Jonathan Goodman, Matthew Jefferson, Metin Uz, Baoqing Guo, Kyoung-Jin Yoon, David Verhoeven, Marian Kohut, Surya Mallapragada, Michael Wannemuehler & Balaji Narasimhan. (2019) Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice. Biomaterials Science 7:3, pages 809-821.
Crossref
Crossref
Jacob E. Kohlmeier, Kenneth H. Ely, Lisa M. Connor, Alan D. Roberts, Eric J. Yager, David L. Woodland & Marcia A. Blackman. 2019. Handbook of Immunosenescence. Handbook of Immunosenescence
1939
1959
.
Erica C. Lorenzo, Jenna M. Bartley & Laura Haynes. (2018) The impact of aging on CD4+ T cell responses to influenza infection. Biogerontology 19:6, pages 437-446.
Crossref
Crossref
Sonia Jain, Parakkal Jovvian George, Wanyan Deng, Joseph Koussa, Kaela Parkhouse, Scott E. Hensley, Jiu Jiang, Jie Lu, Zhuyun Liu, Junfei Wei, Bin Zhan, Maria Elena Bottazzi, Hao Shen & Sara Lustigman. (2018) The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 + T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway. Vaccine 36:25, pages 3650-3665.
Crossref
Crossref
Daniela S. Rajão & Daniel R. Pérez. (2018) Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture. Frontiers in Microbiology 9.
Crossref
Crossref
Byung Wook Yoo, Chang Oh KimAllen IzuAshwani Kumar AroraEsther Heijnen. (2018)
Phase 4, Post-Marketing Safety Surveillance of the MF59-Adjuvanted Influenza Vaccines FLUAD
®
and VANTAFLU
®
in South Korean Subjects Aged ≥65 Years
. Infection & Chemotherapy 50:4, pages 301.
Crossref
Crossref
Jacob E. Kohlmeier, Kenneth H. Ely, Lisa M. Connor, Alan D. Roberts, Eric J. Yager, David L. Woodland & Marcia A. Blackman. 2017. Handbook of Immunosenescence. Handbook of Immunosenescence
1
21
.
Henning Jacobsen, Madhusudan Rajendran, Angela Choi, Haakon Sjursen, Karl A. Brokstad, Rebecca J. Cox, Peter Palese, Florian Krammer & Raffael Nachbagauer. (2017)
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
In Vivo
Protection in a Serum Transfer Mouse Challenge Model
. mBio 8:5.
Crossref
Crossref
Thomas Ebensen, Jennifer Debarry, Gabriel K. Pedersen, Paulina Blazejewska, Sebastian Weissmann, Kai Schulze, Kenneth C. McCullough, Rebecca J. Cox & Carlos A. Guzmán. (2017) Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice. Frontiers in Immunology 8.
Crossref
Crossref
Charlene M.C. Rodrigues, Marta V. Pinto, Manish Sadarangani & Stanley A. Plotkin. (2017) Whither vaccines?. Journal of Infection 74, pages S2-S9.
Crossref
Crossref
Clementine S. Fraser, Akhilesh Jha & Peter J.M. Openshaw. (2017) Vaccines in the Prevention of Viral Pneumonia. Clinics in Chest Medicine 38:1, pages 155-169.
Crossref
Crossref
Jennifer A. Juno, David van Bockel, Stephen J. Kent, Anthony D. Kelleher, John J. Zaunders & C. Mee Ling Munier. (2017) Cytotoxic CD4 T Cells—Friend or Foe during Viral Infection?. Frontiers in Immunology 8.
Crossref
Crossref
David J. Gasper, Brandon Neldner, Erin H. Plisch, Hani Rustom, Emily Carrow, Hirotaka Imai, Yoshihiro Kawaoka & M. Suresh. (2016) Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines. PLOS Pathogens 12:12, pages e1006064.
Crossref
Crossref
Stéphane Pillet, Éric Aubin, Sonia Trépanier, Diane Bussière, Michèle Dargis, Jean-François Poulin, Bader Yassine-Diab, Brian J. Ward & Nathalie Landry. (2016) A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults. Clinical Immunology 168, pages 72-87.
Crossref
Crossref
Srinivas Garlapati. (2016) Decision Analytic Modeling for Cost-Effectiveness Evaluation of Adjuvanted and Non-Adjuvanted Flu Vaccines in the Elderly 65+. International Journal of Vaccines & Vaccination 2:2.
Crossref
Crossref
Deborah M. Brown, Anna T. Lampe & Aspen M. Workman. (2016) The Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza Infection. Frontiers in Immunology 7.
Crossref
Crossref
Karen K. Yam, Jyotsana Gupta, Elizabeth K. Allen, Kayla R. Burt, Édith Beaulieu, Corey P. Mallett, David S. Burt & Brian J. Ward. (2016) Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice. Vaccine 34:12, pages 1444-1451.
Crossref
Crossref
Han Zhang & Mohamed E El Zowalaty. (2016) DNA-based influenza vaccines as immunoprophylactic agents toward universality. Future Microbiology 11:1, pages 153-164.
Crossref
Crossref
Stanley A. Plotkin. (2015) Increasing Complexity of Vaccine Development. Journal of Infectious Diseases 212:suppl 1, pages S12-S16.
Crossref
Crossref
Kuldeep Dhama, Mani Saminathan, Siju Susan Jacob, Mithilesh Singh, K. Karthik, Amarpal .Ruchi Tiwari, Lakshmi Tulasi Sunkara, Yashpal Singh Malik & Raj Kumar Singh. (2015) Effect of Immunomodulation and Immunomodulatory Agents on Health with some Bioactive Principles, Modes of Action and Potent Biomedical Applications. International Journal of Pharmacology 11:4, pages 253-290.
Crossref
Crossref
Carlos A. Sariol & Laura J. White. (2014) Utility, Limitations, and Future of Non-Human Primates for Dengue Research and Vaccine Development. Frontiers in Immunology 5.
Crossref
Crossref
Daire O’Shea, Lukas A. Widmer, Jörg Stelling & Adrian Egli. (2014) Changing Face of Vaccination in Immunocompromised Hosts. Current Infectious Disease Reports 16:9.
Crossref
Crossref
Kamran Haq & Janet E McElhaney. (2014) Immunosenescence: influenza vaccination and the elderly. Current Opinion in Immunology 29, pages 38-42.
Crossref
Crossref
K. M. Neuzil & J. C. Victor. (2013) Editorial Commentary: Annual Studies of Influenza Vaccine Effectiveness: Evaluating Performance, Informing Policy, and Generating New Questions. Clinical Infectious Diseases 58:3, pages 328-329.
Crossref
Crossref